Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Karen F. Kelley"'
Autor:
Helen Ayles, Neshaan Peton, Francoise Louis, Nulda Beyers, Constance Mubekapi-Musadaidzwa, Dillon T. Wademan, Richard J. Hayes, Sarah Fidler, Nelis Grobbelaar, Gabriela Carolus, James Kruger, Peter Bock, Karen F Kelley, Graeme Hoddinott, Rheiner Mbaezue, Portia Hendricks, Karen Jennings
Publikováno v:
African Journal of AIDS Research. 20:32-41
Background: The HPTN 071 (PopART) trial implemented universal test and treat (UTT) in three clinics in the Western Cape, South Africa at a time when antiretroviral treatment (ART) was only offered by CD4 threshold and World Health Organization clinic
Autor:
Karen F. Kelley, Fiona Scorgie, Shamagonam James, Sinead Delany-Moretlwe, Admire Chikandiwa, Hasina Subedar, Nicolette Naidoo, Helen Rees, Yogan Pillay, Nonhlanhla R Dlamini
Publikováno v:
Global Health: Science and Practice
Evaluation of the campaign confirmed its feasibility in this setting: it achieved high coverage, few adverse events, and mostly positive media coverage. However, challenges occurred in data and cold chain management. Future implementation requires im
Autor:
Karen F. Kelley, Sten H. Vermund
Publikováno v:
AIDS. 32:1715-1717
Autor:
Sten H. Vermund, Karen F. Kelley
Publikováno v:
Reproductive and Perinatal Epidemiology ISBN: 9780429278341
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9ae2d6292eebdf9d1e47c287301633e
https://doi.org/10.1201/9780429278341-12
https://doi.org/10.1201/9780429278341-12
Autor:
Diane E Bennett, Ahmed Saadani, Giovanni Ravasi, Karen F. Kelley, Michael R. Jordan, James H McMahon, Silvia Bertagnolio, Steven Y. Hong
Publikováno v:
Clinical Infectious Diseases. 54:S280-S289
The rapid scale-up of antiretroviral therapy (ART) for human immunodeficiency virus (HIV) in resource-limited settings (RLSs) is an international healthcare priority. By December 2010, 6.6 million people living with HIV in low- and middle-income coun
Autor:
Karen F. Kelley, Silvia Bertagnolio, Vincent C. Marconi, Michael R. Jordan, Jean B. Nachega, Steven Y. Hong
Publikováno v:
ResearcherID
Antiretroviral therapy (ART) scale-up in resource limited settings (RLS) has been successful, utilizing a standardized population-based approach to ART delivery. An unintended consequence of treatment scale-up is the inevitable emergence of HIV drug
Autor:
Christine Wanke, Julian Elliott, Sharon R Lewin, Karen F. Kelley, Silvia Bertagnolio, James H McMahon, Michael R. Jordan, Steven Y. Hong
Publikováno v:
Clinical Infectious Diseases. 52:493-506
Prescription or pill-based methods for estimating adherence to antiretroviral therapy (ART), pharmacy adherence measures (PAMs), are objective estimates calculated from routinely collected pharmacy data. We conducted a literature review to evaluate P
Autor:
Carolyn Bolton-Moore, Joanna Busza, Lee Fairlie, Sinead Delany-Moretlwe, Frances M. Cowan, Karen F. Kelley
Publikováno v:
Journal of the International AIDS Society
INTRODUCTION: Adolescence is a time of physical, emotional and social transitions that have implications for health. In addition to being at high risk for HIV, young key populations (YKP) may experience other health problems attributable to high-risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8520624d05358371daae62ad1a2662f7
Autor:
T. Shamu, Michael R. Jordan, Owen Mugurungi, Janet Dzangare, C. Chakanyuka, Tsitsi Apollo, Richard Banda, Karen F. Kelley, F. Cham, Elizabeth Gonese, Diane E Bennett
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 54
Monitoring human immunodeficiency virus drug resistance (HIVDR) early warning indicators (EWIs) can help national antiretroviral treatment (ART) programs to identify clinic factors associated with HIVDR emergence and provide evidence to support natio
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 54
The Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) is the largest funder of human immunodeficiency virus (HIV) prevention and treatment programs worldwide. Since 2002, the Global Fund has encouraged grant recipients to implement dr